Jazz Pharmaceuticals plc — Director's Dealing 2014

Mar 11, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2014-03-07

Reporting Person: WILSON KAREN J (SVP, Finance & PAO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-03-07	Ordinary Shares	M	3000	$59.13	Acquired	27300	Direct
2014-03-07	Ordinary Shares	S	3888	$155.04	Disposed	23412	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-03-07	Nonstatutory Stock Option (right to buy)	$59.13	M	3000	Disposed	2023-03-04	Ordinary Shares (3000)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.03 to $155.077, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.

F2: Following the reported transaction, the remaining ordinary shares subject to this option will vest with respect to 2,250 shares in nine equal monthly installments from April 5, 2014 to December 5, 2014 and with respect to 6,000 shares in twenty-four equal monthly installments from January 5, 2015 to December 5, 2016.